I. V. Terekhova

1.6k total citations
110 papers, 1.3k citations indexed

About

I. V. Terekhova is a scholar working on Pharmaceutical Science, Spectroscopy and Materials Chemistry. According to data from OpenAlex, I. V. Terekhova has authored 110 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pharmaceutical Science, 45 papers in Spectroscopy and 39 papers in Materials Chemistry. Recurrent topics in I. V. Terekhova's work include Drug Solubulity and Delivery Systems (66 papers), Analytical Chemistry and Chromatography (43 papers) and Crystallization and Solubility Studies (35 papers). I. V. Terekhova is often cited by papers focused on Drug Solubulity and Delivery Systems (66 papers), Analytical Chemistry and Chromatography (43 papers) and Crystallization and Solubility Studies (35 papers). I. V. Terekhova collaborates with scholars based in Russia, Germany and Poland. I. V. Terekhova's co-authors include Тatyana V. Volkova, R. S. Kumeev, Artem O. Surov, German L. Perlovich, Oleg V. Kulikov, Navassard V. Karapetyan, Г. А. Альпер, Alexey N. Proshin, Małgorzata Koźbiał and Annette Bauer‐Brandl and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.

In The Last Decade

I. V. Terekhova

107 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. V. Terekhova Russia 20 427 399 372 319 241 110 1.3k
L. Malpezzi Italy 25 287 0.7× 398 1.0× 367 1.0× 233 0.7× 828 3.4× 92 1.7k
K. Gessler Germany 16 337 0.8× 523 1.3× 434 1.2× 244 0.8× 586 2.4× 21 1.6k
Тatyana V. Volkova Russia 22 264 0.6× 665 1.7× 184 0.5× 317 1.0× 661 2.7× 124 1.6k
Federica Balzano Italy 25 365 0.9× 290 0.7× 486 1.3× 733 2.3× 508 2.1× 116 1.9k
Francisco Meijide Spain 25 337 0.8× 428 1.1× 586 1.6× 391 1.2× 992 4.1× 79 1.8k
László Jicsinszky Hungary 23 326 0.8× 386 1.0× 385 1.0× 431 1.4× 303 1.3× 81 1.6k
Joël Jacob Germany 10 278 0.7× 336 0.8× 271 0.7× 190 0.6× 345 1.4× 16 943
José Vázquez Tato Spain 25 425 1.0× 496 1.2× 637 1.7× 487 1.5× 1.1k 4.7× 93 2.1k
Valerian T. D’Souza United States 17 526 1.2× 504 1.3× 731 2.0× 580 1.8× 914 3.8× 43 2.0k
M. Ermelinda S. Eusébio Portugal 22 173 0.4× 755 1.9× 167 0.4× 284 0.9× 633 2.6× 102 1.7k

Countries citing papers authored by I. V. Terekhova

Since Specialization
Citations

This map shows the geographic impact of I. V. Terekhova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. V. Terekhova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. V. Terekhova more than expected).

Fields of papers citing papers by I. V. Terekhova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. V. Terekhova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. V. Terekhova. The network helps show where I. V. Terekhova may publish in the future.

Co-authorship network of co-authors of I. V. Terekhova

This figure shows the co-authorship network connecting the top 25 collaborators of I. V. Terekhova. A scholar is included among the top collaborators of I. V. Terekhova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. V. Terekhova. I. V. Terekhova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terekhova, I. V., et al.. (2024). Complex formation with modified cyclodextrins for improving biopharmaceutical properties of baricitinib, a novel immunomodulatory drug. Journal of Molecular Liquids. 406. 125016–125016. 3 indexed citations
2.
Кочкина, Н. Е., et al.. (2023). β-Cyclodextrin Modified Hydrogels of Kappa-Carrageenan for Methotrexate Delivery. Pharmaceutics. 15(9). 2244–2244. 6 indexed citations
3.
Кочкина, Н. Е., et al.. (2023). Features of the solubilization of leflunomide with Pluronic F127 in biorelevant media FaSSGF and FaSSIF. Journal of Molecular Liquids. 393. 123675–123675. 2 indexed citations
4.
Петренко, В. Е., et al.. (2023). Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod. Журнал физической химии. 97(3). 378–385. 1 indexed citations
5.
Terekhova, I. V., et al.. (2023). Improving properties of baricitinib due to interaction with Pluronic micelles. Journal of Molecular Liquids. 382. 121968–121968. 4 indexed citations
6.
Terekhova, I. V., et al.. (2023). Comparative Analysis of the Effect of Native and Polymeric β-Cyclodextrins on the Solubility and Membrane Permeability of Baricitinib. Russian Journal of Physical Chemistry A. 97(8). 1842–1848. 1 indexed citations
7.
Петренко, В. Е., et al.. (2023). Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod. Russian Journal of Physical Chemistry A. 97(3). 469–476. 4 indexed citations
8.
9.
Volkova, Тatyana V., et al.. (2020). Methotrexate-loaded metal-organic frameworks on the basis of γ-cyclodextrin: Design, characterization, in vitro and in vivo investigation. Materials Science and Engineering C. 111. 110774–110774. 35 indexed citations
10.
Volkova, Тatyana V., Alexey N. Proshin, Anton S. Mazur, et al.. (2017). Improved Biopharmaceutical Properties of Oral Formulations of 1,2,4-Thiadiazole Derivative with Cyclodextrins: in Vitro and in Vivo Evaluation. ACS Biomaterials Science & Engineering. 4(2). 491–501. 12 indexed citations
11.
Volkova, Тatyana V., et al.. (2017). Impact of biorelevant media on pharmacologically important properties of potential neuroprotectors based on 1,2,4-thiadiazole. Journal of Molecular Liquids. 247. 64–69. 5 indexed citations
12.
Surov, Artem O., Тatyana V. Volkova, Andrei V. Churakov, et al.. (2017). Cocrystal formation, crystal structure, solubility and permeability studies for novel 1,2,4-thiadiazole derivative as a potent neuroprotector. European Journal of Pharmaceutical Sciences. 109. 31–39. 39 indexed citations
13.
Volkova, Тatyana V., I. V. Terekhova, Oleg I. Silyukov, et al.. (2016). Towards the rational design of novel drugs based on solubility, partitioning/distribution, biomimetic permeability and biological activity exemplified by 1,2,4-thiadiazole derivatives. MedChemComm. 8(1). 162–175. 26 indexed citations
14.
Terekhova, I. V., et al.. (2014). Cyclodextrin–benzoic acid binding in salt solutions: Effects of biologically relevant anions. Carbohydrate Polymers. 110. 472–479. 7 indexed citations
15.
Terekhova, I. V., et al.. (2013). Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection. SHILAP Revista de lepidopterología. 42–45. 2 indexed citations
16.
Kumeev, R. S., et al.. (2013). α-Cyclodextrin/aminobenzoic acid binding in salt solutions at different pH: Dependence on guest structure. International Journal of Biological Macromolecules. 57. 255–258. 5 indexed citations
17.
Shubin, Vladimir V., et al.. (2010). Variability of light-induced circular dichroism spectra of photosystem I complexes of cyanobacteria. Applied Biochemistry and Microbiology. 46(3). 274–281. 1 indexed citations
18.
Terekhova, I. V., R. S. Kumeev, & Г. А. Альпер. (2007). The interaction of caffeine with substituted cyclodextrins in water. Russian Journal of Physical Chemistry A. 81(7). 1071–1075. 10 indexed citations
20.
Terekhova, I. V. & Oleg V. Kulikov. (2002). Thermodynamics of the interactions of ascorbic acid with α- and β-cyclodextrins in aqueous solutions. Mendeleev Communications. 12(3). 111–112. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026